NCT07314021

Brief Summary

42 women diagnosed with primary dysmenorrhea were included in the study and divided into three groups. the first group received treatment with a mobilization approach, the second group received motor imagery-focused exercises and the third group, as a control group received electrotherapy. all three groups received electrotherapy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 7, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

January 2, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2026

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2026

Completed
Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

7 months

First QC Date

December 4, 2025

Last Update Submit

December 30, 2025

Conditions

Keywords

mobilizationprimary dysmenorrheaexercise

Outcome Measures

Primary Outcomes (1)

  • McGill pain scale short form

    The characteristic of pain felt by the patients during menstruation was evaluated using the McGill Pain Questionnaire-Short Form,With the McGill Melzack Pain Questionnaire, the location of the pain, the feeling it creates in the individual, its relationship with time, its severity and the level of viable pain for the individual are determined. High score indicates high level of pain

    5 minutes

Secondary Outcomes (4)

  • Menstrual Attitude Questionnaire

    5 minutes

  • Functional and Emotional Dysmenorrhea Scale

    5 minutes

  • Menstrual Symptom Questionnaire

    5 minutes

  • The Menstrual Distress Questionnaire

    5 minutes

Study Arms (3)

FEMOB

ACTIVE COMPARATOR

Transcutaneous Electrical Nerve Stimulation (TENS) treatment will be applied to the lumbar and suprapubic areas using 2 channels and 4 electrodes. Conventional TENS (120 Hz) will be applied simultaneously to the lumbar and suprapubic areas for 30 minutes. Hot pack application will be done sequentially to the lumbar and suprapubic areas for 15 minutes each, for a total of 30 minutes. FEMOB is a mobilization model that includes temporo-mandibular, occipito-sacral, and sacroiliac joint mobilizations along with abdominal myofascial release and kinesio taping.

Other: MOPEXEOther: CONTROL

MOPEXE

ACTIVE COMPARATOR

Transcutaneous Electrical Nerve Stimulation (TENS) treatment will be applied to the lumbar and suprapubic areas using 2 channels and 4 electrodes. Conventional TENS (120 Hz) will be applied simultaneously to the lumbar and suprapubic areas for 30 minutes. Hot pack application will be done sequentially to the lumbar and suprapubic areas for 15 minutes each, for a total of 30 minutes. 5 minute-Meditation Therapy 10 minute-Progressive Relaxation training ( Bernstein-Borkovec Method) 5 min - Breathing Exercises (Diaphragmatic Breathing Exercise, Pursed lip breathing Exercise) 35 min -Motor Imagery Technique Focused Pelvic Floor Exercises-MOPEXE 5 min - Meditation Therapy Twice a week for 60 minutes 12 weeks Participants will be evaluated online at the beginning of the research and at the end of the 12-week program.

Other: FEMOBOther: CONTROL

CONTROL

OTHER

Transcutaneous Electrical Nerve Stimulation (TENS) treatment will be applied to the lumbar and suprapubic areas using 2 channels and 4 electrodes. Conventional TENS (120 Hz) will be applied simultaneously to the lumbar and suprapubic areas for 30 minutes. Hot pack application will be done sequentially to the lumbar and suprapubic areas for 15 minutes each, for a total of 30 minutes.

Other: FEMOBOther: MOPEXE

Interventions

FEMOBOTHER

Transcutaneous Electrical Nerve Stimulation (TENS) treatment will be applied to the lumbar and suprapubic areas using 2 channels and 4 electrodes. Conventional TENS (120 Hz) will be applied simultaneously to the lumbar and suprapubic areas for 30 minutes. Hot pack application will be done sequentially to the lumbar and suprapubic areas for 15 minutes each, for a total of 30 minutes. FEMOB is a mobilization model that includes temporo-mandibular, occipito-sacral, and sacroiliac joint mobilizations along with abdominal myofascial release and kinesio taping.

CONTROLMOPEXE
MOPEXEOTHER

Transcutaneous Electrical Nerve Stimulation (TENS) treatment will be applied to the lumbar and suprapubic areas using 2 channels and 4 electrodes. Conventional TENS (120 Hz) will be applied simultaneously to the lumbar and suprapubic areas for 30 minutes. Hot pack application will be done sequentially to the lumbar and suprapubic areas for 15 minutes each, for a total of 30 minutes. 5 minute-Meditation Therapy 10 minute-Progressive Relaxation training ( Bernstein-Borkovec Method) 5 min - Breathing Exercises (Diaphragmatic Breathing Exercise, Pursed lip breathing Exercise) 35 min -Motor Imagery Technique Focused Pelvic Floor Exercises-MOPEXE 5 min - Meditation Therapy Twice a week for 60 minutes 12 weeks Participants will be evaluated online at the beginning of the research and at the end of the 12-week program.

CONTROLFEMOB
CONTROLOTHER

Transcutaneous Electrical Nerve Stimulation (TENS) treatment will be applied to the lumbar and suprapubic areas using 2 channels and 4 electrodes. Conventional TENS (120 Hz) will be applied simultaneously to the lumbar and suprapubic areas for 30 minutes. Hot pack application will be done sequentially to the lumbar and suprapubic areas for 15 minutes each, for a total of 30 minutes.

FEMOBMOPEXE

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • primary dysmenorrhea

You may not qualify if:

  • a contraindicated condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medipol University

Istanbul, 34000, Turkey (Türkiye)

Location

Related Publications (1)

  • Toprak Celenay S, Kavalci B, Karakus A, Alkan A. Effects of kinesio tape application on pain, anxiety, and menstrual complaints in women with primary dysmenorrhea: A randomized sham-controlled trial. Complement Ther Clin Pract. 2020 May;39:101148. doi: 10.1016/j.ctcp.2020.101148. Epub 2020 Mar 18.

Related Links

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physiotherapist

Study Record Dates

First Submitted

December 4, 2025

First Posted

January 2, 2026

Study Start

July 7, 2025

Primary Completion

February 3, 2026

Study Completion

February 15, 2026

Last Updated

January 2, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations